Misguided “Buy American” Mandates Risk Catastrophic Consequences
June 22, 2020 As countries across the globe slowly begin the recovery from COVID-19,while also bracing for a possible second...
CASE Op-ed – Townhall: Democrats’ Covid Cure is a Death Sentence for Life-Saving Innovation
Gerard Scimeca – Chairman, CASE June 5, 2020 In pitching their legislative priorities for the next round of Covid relief,...
Coronavirus Highlights the Necessity of a Robust Private Sector
April 16, 2020 On January 21, 2020, the Centers for Disease Control and Prevention (CDC) confirmed the first case...
CASE Op-Ed – Washington Times: Hospital Pre-payment is the Wrong Response to Beating Covid-19
Gerard Scimeca – Chairman, CASE April 16, 2020 In news that should surprise absolutely nobody, America’s healthcare professionals have...
Trump Must Abandon Ill-Timed “Buy American” Drug Mandate
March 18, 2020 Prior to the interruptions caused due to the coronavirus, the Trump economy was surging. One of...
CASE Statement: Pending Congressional Amendment to Have Devastating Effect on Medical Innovation
March 10, 2020 Contact: Gerard Scimeca, CASE co-founder and Chairman CASE Statement in Opposition to “No Ban Act” Adoption of...
Corona Virus Funding Legislation Shouldn’t Be Used to Push Socialized Medicine
March 4, 2020 CASE issued the following statement this morning regarding attempts by some in Congress to use corona virus...
CASE Launches New Ad: Don’t Let HHS Put Insurer Interests Over Patient Savings
See Ad Here: February 19, 2020 If there is one goal Republicans and Democrats have in common these days,...
CASE Op-Ed – RealClear Markets: Nancy Pelosi’s Price Fixing Scheme Threatens Drug Innovation
Gerard Scimeca – Chairman, CASE January 7, 2020 Addressing sky-high healthcare costs is a pressing need in our country,...
CASE Op-Ed – Naples Daily News: Congress Must Pass Market-Based Approach to Address Surprise Billing
December 19, 2019 Surprise medical billing creates undue financial hardships for patients and their families at a time when all...
.@POTUS’ IRA is driving up Part D premiums for millions of Medicare beneficiaries, yet Dems like @SenSanders continue to help tout this disastrous legislation. The Biden-Harris @WhiteHouse is misleading the public on their policy’s real impact.
Two weeks from election day, the supposedly independent @FCC is proposing price regulation of #broadband by restricting what data plans companies can offer.
By prohibiting usage-based plans, the FCC would end up increasing prices FOR EVERYONE, including low-data users!
CASE Letter Urges FDA & FTC to Scrutinize Deal Between L’Oréal and Galderma -- "Both companies are currently under investigation or facing sizable lawsuits from claims that they have used harmful chemicals in their products."
https://caseforconsumers.org/2024/10/21/case-letter-urges-fda-ftc-to-scrutinize-deal-between-loreal-and-galderma/